This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in de

EU and US Antitrust Arbitration is the first book that deals with how both of the world's leading antitrust systems, US and EU law, are treated in international

Public health, safety and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and com